Fumiko Ladd Chino: Screening for financial toxicity can help thousands of patients
Fumiko Ladd Chino recently shared a post by Henry Conter, Portfolio Manager of Early Development Clinical Oncology at Roche, on X and added:
“Screening for financial toxicity and health-related social risks can help thousands of patients. We need to find ways to improve acceptance rates and must continually reassess the program to ensure that our ‘help’ actually rises outcomes for patients. Can’t wait for Dr. Bridgette Thom’s ASCO 24 talk!”
Quoting Henry Conter’s post:
“Fumiko Ladd Chino shows 16% of patients screened for financial toxicity and social risks ultimately access financial counselling.
Of those, 15% got a cost reduction program and 15% help with insurance navigation. So at most, 5% of all patients screened benefited related to FT.”
Source: Fumiko Ladd Chino/X and Henry Conter/X
Fumiko Ladd Chino is a cancer researcher and Assistant Attending in Radiation Oncology at Memorial Sloan Kettering Cancer Center (USA), who specializes in gynecological and breast cancers. She was also a caregiver for her husband Andrew Mark Ladd, PhD who died from cancer in 2007.
She is a recipient of numerous awards, including ASCO Excellence in Equity Award (2022), Duke Radiation Oncology Award for Outstanding Clinical Research (2019), Duke University Hospital “Good Catch” Award (2018), Conquer Cancer Foundation of ASCO Merit Award (2018), Duke University School of Medicine Dean’s Recognition Award (2014) and Memorial Hermann Hospital, Texas Medical Center Volunteer of the Year Award (2009).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023